<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>njbms</PublisherName>
      <JournalTitle>NJBMS</JournalTitle>
      <PISSN>0976-6626</PISSN>
      <EISSN>2455-1740</EISSN>
      <Volume-Issue>Volume 12, Issue 2</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>October - December 2021</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>30</Day>
      </PubDate>
      <ArticleType>Biochemistry</ArticleType>
      <ArticleTitle>LEPTIN- a key player in chronic kidney diseaseLEPTIN- a key player in chronic kidney disease</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>44</FirstPage>
      <LastPage>50</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Ponnudhali D</FirstName>
          <LastName/>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Nagarajan</FirstName>
          <LastName>P</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI/>
      <Abstract>Background: Leptin is an adipose derived protein hormone, involved in body weight regulation. It is found to play an important role in the development of chronic kidney disease (CKD) by various metabolic and inflammatory mechanisms.&#13;
&#13;
Aim: To assess the serum leptin levels in chronic kidney disease and to analyze its correlation with GFR, BMI, insulin and insulin resistance.&#13;
&#13;
Materials __ampersandsign methods: Serum leptin and insulin levels were measured in 45 non-diabetic CKD patients (group 1) and 45 healthy controls (group 2). Serum leptin and insulin were measured using DRG __ampersandsign Monobind ELISA kits. HOMA- IR __ampersandsignBMI were calculated and the values taken. The statistical analysisof Independent student t- test __ampersandsign Pearson’s correlation were performed using SPSS 26 software. &#13;
&#13;
Results:  Serum Leptin levels were significantly increased in group 1 -CKD patients (15.8 ---PlusMinusSymbol--- 2.76ng/ml) compared with group 2 -healthy controls (6.31---PlusMinusSymbol--- 0.87 ng/ml) P=0.003. Serum insulin levels were also significantly increased in the CKD group (14.34 ---PlusMinusSymbol--- 8.23 µU/ml) from that of healthy individuals (6.40 ---PlusMinusSymbol--- 1.16 µU/ml), P= 0.000. There were positive significant correlations of serum leptin with BMI__ampersandsign Insulin (p=0.000)__ampersandsign negative correlation of leptin with GFR.&#13;
&#13;
Conclusion: Leptin may independently contribute to GFR decline in the kidney and could have a nephrotoxic potential, resulting in CKD.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>Leptin, chronic kidney disease, CKD, leptin resistance, insulin resistance.</Keywords>
      <URLs>
        <Abstract>https://njbms.in/ubijournal-v1copy/journals/abstract.php?article_id=13723&amp;title=LEPTIN- a key player in chronic kidney diseaseLEPTIN- a key player in chronic kidney disease</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: The metabolic syndrome  and chronic kidney disease in US adults. Ann Intern Med 140: 167–175, 2004&#13;
	Ninomiya JK, L’Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS: Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 109: 42–46, 2004&#13;
	Claudio Pedone1 et al. Longitudinal Association between Serum Leptin Concentration and Glomerular Filtration Rate in Humans.PLOS ONE;2015DOI:10.1371/journal.pone.0117828&#13;
	Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive- leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292–295.PMID: 8532024&#13;
	Menon V, Wang X, Greene T, Beck GJ, Kusek JW, Marcovina SM, et al. Factors associated with serum leptin in patients with chronic kidney disease. Clin Nephrol 2004; 61: 163–169. PMID: 15077866&#13;
	Paul Trayhurn1* and John H. Beattie2 Physiological role of adipose tissue:white adipose tissue as an endocrine and secretory organ.Proceedings of the Nutrition Society .2001; 60: 329- 339&#13;
	Amal A. El-Mahdy1 ,Eithar K. El-Adham1*, A. M. El-Waseef2, , M. A. Mosleh1Serum Insulin and Leptin Levels in Chronic Renal Failure Patients Using Radiometric Techniques.International Journal of Advanced Research (2014), Volume 2, Issue 11, 352-360&#13;
	EDDINE MERABET, SAMUEL DAGOGO-JACK, DANIEL W. COYNE, SAMUEL KLEIN, JULIO V. SANTIAGO, S. PAUL HMIEL, AND MICHAEL LANDT.Increased Plasma Leptin Concentration in End-Stage Renal Disease*Journal of Clinical Endocrinology and Metabolism.1997;Vol. 82, No. 3:847-850&#13;
	RateGraham RD Jones and Ee-Mun Lim. The National Kidney Foundation Guideline on Estimation of the Glomerular Filtration.ClinBiochem Rev. Aug 2003; 24(3): 95–98.&#13;
	Nazish Rafique, Mohammad Nasir Afzal. Relationship of serum leptin levels with body mass index and gender.RMJ. 2009; 34(2): 164-166.&#13;
	A Piyali das et al. Association of obesity and leptin with insulin resistance in type 2 diabetes mellitus in indian population. Indian J Physiol Pharmacol.2013; 57(1): 45-50.&#13;
	Ali Movahed et al. Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients. Evidence-Based Complementary and Alternative Medicine. Volume 2013, 1-11.&#13;
	Wieneke Marleen Michels et al. Performance of the Cockcroft- Gault, MDRD, and New CKDEPI Formulas in Relation to GFR, Age, and Body Size. Clin J Am Soc Nephrol. 2010; 5:1003–1009.&#13;
	Anoop Shankar,1 Shirmila Syamala,2 Jie Xiao,1 and PaulMuntner3Relationship between Plasma Leptin Level and Chronic Kidney Disease.Volume 2012, Article ID 269532: 1-6 doi:10.1155/2012/269532&#13;
	Cynthia Ciwei Lim et al. Elevated Serum Leptin, Adiponectin and Leptin to Adiponectin Ratio Is Associated with Chronic Kidney Disease in Asian Adults.2015;PLOS ONE: 1-11  DOI:10.1371/journal.pone.0122009&#13;
	Rodrigo Bueno de  etal.The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients.Clin Kidney J (2013) 6: 63–70&#13;
	Bossola M, Muscaritoli M, Valenza V, et al. Annorexia and serum leptin levels in hemodialysis patients. Nephron Clin Pract2004;97:76-82.&#13;
	Wolf G, Hamann A, Han DC, Helmchen U, Thaiss F, Ziyadeh FN, et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis.Kidney Int 1999; 56: 860–872.&#13;
	Wolf G, Ziyadeh FN. Leptin and renal fibrosis. Contrib Nephrol. 2006; 151: 175–183&#13;
	 Christiane Rand;uuml;ster and GunterWolf.Adipokines promote chronic kidney disease.Nephrol Dial Transplant (2013) 28 (Suppl. 4): iv8–iv14&#13;
	G. Wolf, A. Hamann, D. C. Han et al., “Leptin stimulates proliferation and TGF-and;beta; expression in renal glomerular endothelial cells:potential role in glomerulosclerosis,” Kidney International, vol. 56, no. 3, pp. 860–872, 1999.&#13;
	G. Wolf, S. Chen, D. C. Han, and F. N. Ziyadeh, “Leptin and renal disease,” American Journal of Kidney Diseases, vol. 39, no. 1, pp. 1–11, 2002.&#13;
	G. Wolf and F. N. Ziyadeh, “Leptin and renal fibrosis,” Contributions to Nephrology, vol. 151, pp. 175–183, 2006.&#13;
	Beltowski J, Jamroz-Wisniewska A, Wojcicka G et al. Renal antioxidant enzymes and glutathione redox status in leptin-induced hypertension. Mol Cell Biochem 2008; 319: 163–174&#13;
	E. K. Jackson and P. Li, “Human leptin has natriuretic activity in the rat,” American Journal of Physiology, vol. 272, no. 3, pp. F333–F338, 1997&#13;
	J. E. Hall, H. L. Mizelle, D. A. Hildebrandt, and M.W. Brands, “Abnormal pressure natriuresis. A cause or a consequence of hypertension?” Hypertension, vol. 15, no. 6, pp. 547–559, 1990.&#13;
	The Biology of Leptin: A Review Karen L. Houseknecht*, Clifton A. Baile†, Robert L. Matteri‡, and Michael E. Spurlock§&#13;
	Hamilton BS, Paglia D, Kwan AY and;Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nature Medicine 1995 1 953±956.&#13;
	Caro JF, Sinha MK, Kolaczynski JW, Zhang PL and; Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996;45 :1455± 1462.&#13;
	Cleand;Acirc;ment K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998 392 398±401.&#13;
	Thompson DB, Ravussin E, Bennett PH and; Bogardus C. Structure and sequence variation at the human leptin receptor gene in lean and obese Pima Indians. Human and Molecular Genetics 1997 6 675±679.&#13;
	30 Chung WK, Power-Kehoe L, Chua M, Chu F, Aronne L, Huma Z et al. Exonic and intronic sequence variation in the human leptin receptor gene (LEPR). Diabetes 1997 46 1509±1511.&#13;
	MachteldWauters, Robert V Considine1 and Luc F Van Gaal Human leptin: from an adipocyte hormone to anendocrine mediator.European Journal of Endocrinology. 2000;143: 293±311&#13;
	Obineche EN, Gillett MP, Abdulle A, Sulaiman M, Al-Rokhaimi M. Leptin and lipid metabolism related hormones in chronic renal failure in Arabia. Nephrology 2002;7:115-120.&#13;
	Emilsson, V., Y. Liu, M. A. Cawthorne, N. M. Morton, and M. Davenport. 1997. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 46:313-316.&#13;
	 Kieffer, T. J., R. S. Heller, C. A. Leech, G. G. Holz, and J. F. Habener. 1997. Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic b-cells. Diabetes 46:1087-1093.&#13;
	Lostao MP, Urdaneta E, Martinez-Anso E, Barber A and; Martinez JA (1998) Presence of leptin receptors in rat small intestine and leptin effect on sugar absorption. FEBS Letters 423, 302-306.&#13;
	Nakata M, Yada T, Soejima N and; Maruyama I (1999) Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes 48, 426-429.&#13;
	Cohen B, Novick D and; Rubinstein M. Modulation of insulin activities by leptin. Science 1996;274: 1185±1188.&#13;
	Pelleymounter M, Cullen M, Baker M, Hecht R,Winters D, Boone T et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995 269 540±543.&#13;
	StephensTW, BasinskiM, BristowPK, Bue-Vallesky JM, Burgett SG, Craft L et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995 377 530±532.&#13;
	Muzzin P, Eisensmith RC, Copeland KC and; Woo SL. Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. PNAS 1996 93 14804±14808.</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>